Boulder, Colorado — According to state and local development sources, Mosaic Biosciences plans to invest $2,273,027.40 to build out 18,370 square feet of new space in Boulder. The company plans to occupy the new space at 5710 Flatiron Pkwy in Boulder, on or about September 1, 2023. According to the company website Mosaics biopharmaceutical teams turn ideas into reality. We provide experienced biopharma leadership and cross-functional teams to accelerate your protein therapeutic research and development program We work with innovative biotech leaders to bring ideas to fruition: Validating and refining platform and product concepts. Translating leads into clinical development candidates. Designing and leading IND-enabling activities and managing IND preparation. Designing and implementing early clinical proof-of-concept studies. Assisting in fundraising. How we work with you: We work as an extension of your company – your objectives are our objectives. We can participate at nearly any program stage, working with you to define objectives, create a project plan, and determine who is best-suited to conduct the work. We can collaborate or work independently to execute any program from idea to clinical proof-of-concept. We offer flexible financial structures, including cost-based structures (with all product-related program IP owned by you), shared risk and reward arrangements, collaborations, or partnerships.

To learn more about Mosaic Biosciences, visit http://mosaicbio.com/

Company Contact:
Eric Furfine, Chief Executive Officer
https://www.linkedin.com/in/eric-furfine-3a65a26/
720-535-8427

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.